Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia

Cellular and Molecular Neurobiology

Volumn 24, Issue 6, 2004, Pages 769-780

  Väisänen, Jussi ^a   Ihalainen, Jouni ^a   Tanila, Heikki ^a,b   Castrén, Eero ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

c fos; MK801; Neural circuits; NMDA; Schizophrenia

Indexed keywords

DIZOCILPINE; KETAMINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MAPPING; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DOPAMINE RELEASE; ENTORHINAL CORTEX; GENE EXPRESSION; GRANULE CELL; IN SITU HYBRIDIZATION; LATERAL RETICULAR NUCLEUS; MALE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OLFACTORY NUCLEUS; ONCOGENE C FOS; PARIETAL LOBE; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; THALAMUS; VENTRAL TEGMENTUM;

ANIMALS; BRAIN; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; GENES, FOS; HUMANS; MALE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

ANIMALIA;

EID: 12944299304     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-004-6918-7     Document Type: Article

References (36)

1. Andreasen, N. C. (1999). A unitary model of schizophrenia - Bleuler's "fragmented phrene" as schizencephaly. Arch. Gen. Psychiatry 56:781-787.
2. Braff, D. L. (1999). Connecting the "dots" of brain dysfunction in schizophrenia. Arch. Gen. Psychiatry 56:791-793.
3. Castrén, E., Berzaghi, M. P., Lindholm, D., and Thoenen, H. (1993). Differential effects of MK-801 on the brain-derived neurotrophic factor mRNA levels in different regions of rat brain. Exp. Neurol. 122:244-252.
4. DeLeonibus, E., Mele, A., Oliverio, A., and Pert, A. (2002). Distinct pattern of c-fos mRNA expression after systematic and intra-accumbens amphetamine and MK-801. Neuroscience 115:67-78.
5. Dragunow, M., and Faull, R. L. M. (1990). MK-801 induces c-fos protein in thalamic and neocortical neurons of rat brain. Neurosci. Lett. 113:144-150.
6. Farber, N. B., Wozniak, D. F., Price, M. T., Labruyere, J., Huss, J., St. Peter, H., and Olney, J. W. (1995). Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia? Biol Psychiatry 38:788-796.
7. Farber, N. F., Price, M. T., Labruyere, J., Nemnich, J., St. Peter, H., Wozniak, D. F., and Olney, J. W. (1993). Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol. Psychiatry 34:119-121.
8. Gass, P., Herdegen, T., Bravos, R., and Kiessling, M. (1993). Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Neuroscience 53:749-758.
9. Gogos, J. A., and Karayiorgou, M. (2001). "Targeting" schizophrenia in mice. Am. J. Med. Genet. 105:50-52.
10. Hughes, P., and Dragunow, M. (1995). Induction of immediate early genes and the control of neurotransmitter-regulated gene-expression within the nervous system. Pharmacol. Rev. 47:134-178.
11. Ihalainen, J. A., and Tanila, H. (2002). In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse prefrontal cortex. Eur. J. Neurosci. 15:1789-1794.
12. Javitt, D. C., and Zukin, S. R. (1991). Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148:1301-1308.
13. Kashiwa, A., Nishikawa, T., Nishijima, K., Umino, A., and Takahashi, K. (1995). Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex. Neurochem. Int. 26:269-279.
14. Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Bremner, J. D., Heninger, G. R., Bowers, M. B., and Charney, D. S. (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51:199-214.
15. Kurachi, M. (2003a). Pathogenesis of schizophrenia: Part 1. Symptomology, cognitive characteristics and brain morphology. Psychiatry Clin. Neurosci. 57:3-8.
16. Kurachi, M. (2003b). Pathogenesis of schizophrenia: Part II. Temporo-frontal two step hypothesis. Psychiatry Clin. Neurosci. 57:9-15.
17. Lahti, A. C., Koffel, B., LaPorte, D., and Tamminga, C. (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19.
18. Lee, S., Rivier, C., and Torres, G. (1994). Induction of c-fos and CRF mRNA by MK801 in the parvocellular paraventricular nucleus of the rat hypothalamus. Mol. Brain Res. 24:192-198.
19. Morgan, J. I., and Curran, T. (1991). Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:421-451.
20. Näkki, R., Sharp, F. R., and Sagar, S. M. (1996). Fos expression in the brainstem and cerebellum following phencyclidine and MK-801. J. Neurosci. Res. 43:203-212.
21. Olney, J. W., Labruyere, J., and Price, M. T. (1989). Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362.
22. Paxinos, G. and Watson, C. (1986). The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney.
23. Riedel, G., Platt, B., and Micheau, J. (2003). Glutamate receptor function in learning and memory. Behav. Brain Res. 140:1-47.
24. Rose, J. E., and Woolsey, C. N. (1948). The orbitofrontal cortex and its connections with the mediodorsal nucleus in rabbit, sheep and cat. Res. Publ. Ass. Nerv. Ment. Dis. 27:210-232.
25. Schmidt, C. J., Fadayel, G. M. (1996). Regional effects of MK-801 on dopamine release: Effects of competitive NMDA or 5-HT2A receptor blockade. J. Pharmacol. Exp. Ther. 277:1541-1549.
26. Sharp, F. R., Jasper, P., Hall, J., Noble, L., and Sagar, S. M. (1991). MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann. Neurol. 30:801-809.
27. Sharp, F. R., Tomitaka, M., Bernaudin, M., and Tomitaka, S. (2001). Psychosis: Pathological activation of limbic thalamocortical circuits by psychotomimetics and schizophrenia? Trends Neurosci. 24:330-334.
28. Taffe, M. A., Davis, S. A., Gutierrez, T., and Gold, L. H. (2002). Ketamine impairs multiple cognitive domains in rhesus monkey. Drug Alcohol Depend. 68:175-187.
29. Tekin, S., and Cummings, J. L. (2002). Frontal-subcortical circuits and clinical neuropsychiatry - An update. J. Psychosom. Res. 53:647-654.
30. Thaker, G. K., and Carpenter, W. T., Jr. (2001). Advances in schizophrenia. Nat. Med. 7:667-671.
31. Tomitaka, S., Tomitaka, M., Tolliver, B. K., and Sharp, F. R. (2000). Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK801) injures pyramidal neurons in rat retrosplenial cortex. Eur. J. Neurosci. 21:1420-1430.
32. Uylings, H. B., and van Eden, C. G. (1990). Qualitative and quantitative comparison of the prefrontal cortex in rat and in primates, including humans. Prog. Brain Res. 85:31-62.
33. Väisänen, J., Lindén, A. M., Lakso, M., Wong, G., Heinemann, U., and Castrén, E. (1999). Excitatory actions of NMDA receptor antagonists in rat entorhinal cortex and cultured entorhinal cortical neurons. Neuropsychopharmacology 21:137-146.
34. Verma, A., and Moghaddam, B. (1996). NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: Modulation by dopamine. J. Neurosci. 16:373-379.
35. Wisden, W., and Morris, B. (1994). In situ hybridization with synthetic oligonucleotide probes. In Wisden, W., and Morris, B. (eds.), In Situ Hybridization Protocols for Neurobiology, Academic Press. London. pp. 1-34.
36. Zhang, D. X., and Bertram, E. H. (2002). Midline thalamic region: Widespread excitatory input to the entorhinal cortex and amygdala. J. Neurosci. 22:3277-3284.